| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 88167-35-5 | 1-(2-Propyn-1-yl)-2(1H)-pyrimidinone | C7H6N2O |
| 88168-74-5 | 3-Methyl-3-sulfanyl-D-isovaline | C6H13NO2S |
| 88169-21-5 | 2-(1H-1,2,3-Triazol-4-Yl)Pyridine | C14H12N8 |
| 88169-58-8 | 2'-(2-Acetamidoethyl)-N-{4-[(diaminomethylene)amino]butyl}-2,4'-bi-1,3-thiazole-4-carboxamide hydrochloride (1:1) | C16H24ClN7O2S2 |
| 88169-61-3 | S-(2-Bromoethyl)-L-cysteine | C5H10BrNO2S |
| 88170-22-3 | Decanoic-D19 Acid | |
| 88170-32-5 | 1-Dodecanol-1-13C | |
| 88170-33-6 | 1-Bromododecane-1-13C | |
| 88171-14-6 | L-Threonyl-L-lysyl-L-prolyl-L-lysyl-L-threonyl-L-lysyl-L-prolyl-N5-(diaminomethylene)-L-ornithine | C42H78N14O11 |
| 88172-66-1 | N-[2-(Methacryloyloxy)ethyl]-N,N-dimethyl-3-(trimethoxysilyl)-1-propanaminium bromide | C14H30BrNO5Si |
| 88179-71-9 | 3-Oxochola-4,6-dien-24-oic acid | C24H34O3 |
| 88181-11-7 | N-[(1,1-Dimethylethoxy)Carbonyl]-L-Alanine-2-D | |
| 88181-59-3 | Pyrazino[2,3-f]quinoxaline, chloride, ruthenium(2+) salt (3:1) | C30H18ClN12Ru |
| 88182-33-6 | Levistolid A | C24H28O4 |
| 88183-49-7 | 2-ethoxypropan-1-amine | |
| 88183-82-8 | 3',5'-O-[Tetrakis(1-methylethyl)-1,3-disiloxanediyl]guanosine | C22H39N5O6Si2 |
| 88185-17-5 | Chloro(2,5-dimethoxybenzyl)magnesium | C9H11ClMgO2 |
| 88185-31-3 | 1-[(2E)-3-Phenyl-2-propen-1-yl]piperazine dihydrochloride | C13H20Cl2N2 |
| 88187-82-0 | 2-Methyl-4-biphenylol | C13H12O |
| 88187-83-1 | 4,4'-Cyclohexylidenebis(3-Methylphenol) | C20H24O2 |
| 88187-84-2 | 4-Anilino-4-methyl-2-pentanone | C12H17NO |
| 88189-03-1 | Bismuth(III) trifluoromethanesulfonate | C3BiF9O9S3 |
| 88190-77-6 | 6-Chloro-1,4-Dihydro-4-Phenyl-2-Quinazolinecarboxylic Acid | C15H11ClN2O2 |
| 88190-78-7 | 4-Ethyl-1,3-benzothiazole-2(3H)-thione | C9H9NS2 |
| 88190-97-0 | 9,10-Dihydrobenzo[e]pyrene-9,10-diol | C20H14O2 |
| 88191-01-9 | 1,3,8-Trimethyl-3,9-dihydro-1H-purine-2,6-dione | C8H10N4O2 |
| 88191-14-4 | 3,5,9-Trihydroxyergosta-7,22-dien-6-one | C28H44O4 |
| 88191-22-4 | 3-(3,4-Dihydroxyphenyl)-1-(4-hydroxyphenyl)-2-propen-1-one | C15H12O4 |
| 88191-39-3 | {[(3E)-3-Hexen-1-yloxy]methyl}benzene | C13H18O |
| 88191-48-4 | DL-Catechin | |
| 88191-63-3 | (2S,2'S)-N,N'-(1,2-Hydrazinediylbis{[(2S)-1-oxo-3-phenyl-1,2-propanediyl]imino[(2R)-1-oxo-1,2-propanediyl]})bis[2-amino-3-(4-hydroxyphenyl)propanamide] | C42H50N8O8 |
| 88191-66-6 | (2S,2'S)-N,N'-{1,2-Hydrazinediylbis[(2S)-1-oxo-3-phenyl-1,2-propanediyl]}bis{1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-2-pyrrolidinecarboxamide} | C46H54N8O8 |
| 88191-84-8 | Calpain Inhibitor III | C22H26N2O4 |
| 88192-18-1 | 3-Azidoalanine | C3H6N4O2 |
| 88192-19-2 | 3-Azido-1-propanamine | C3H8N4 |
| 88192-20-5 | 4-Azidobutylamine | C4H10N4 |
| 88192-22-7 | (2R,5R)-6-Heptyne-2,5-diamine | C7H14N2 |
| 88192-98-7 | Methyl [(1E,5R)-5-{5-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-6-hydroxy-4-oxo-4H-pyran-2-yl}-1-hexen-1-yl]carbamate | C23H31NO6 |
| 88192-99-8 | Methyl [(1E,5R)-5-{5-[(2E,4E)-2,5-dimethyl-2,4-nonadienoyl]-6-hydroxy-4-oxo-4H-pyran-2-yl}-1-hexen-1-yl]carbamate | C24H33NO6 |
| 88193-04-8 | 5,9-Dimethyl-7H-dibenzo[c,g]carbazole | C22H17N |
| 88193-28-6 | 6-Oxo-2-piperidinecarbohydrazide | C6H11N3O2 |
| 88194-24-5 | N-[(1S)-3-Amino-1-carboxy-3-oxopropyl]-D-glutamic acid | C9H14N2O7 |
| 88195-59-9 | (8S,9S)-4-(Hydroxymethyl)-8,9-dihydro-8,9-tetraphenediol | C19H16O3 |
| 88195-60-2 | (10S,11S)-4-(Hydroxymethyl)-10,11-dihydro-10,11-tetraphenediol | C19H16O3 |
| 88196-70-7 | (R)-1-(3-Methoxyphenyl)ethylamine | C9H13NO |
| 88197-30-2 | 4-(4'-{[(3-Hydroxy-3,4-dihydro-2H-1,5-benzodioxepin-3-yl)methyl]sulfanyl}-4-biphenylyl)-2,4-dioxobutanoic acid | C26H22O7S |
| 88197-41-5 | Tert-Butoxycarbonylamino-(4-Tert-Butoxycarbonylamino-Phenyl)-Acetic Acid | C18H26N2O6 |
| 88199-82-0 | Methyl (9Z,11S)-11-hydroxy-11-[(2R,3R)-3-pentyl-2-oxiranyl]-9-undecenoate | C19H34O4 |
| 88200-01-5 | (-)-Chelidonine | C20H19NO5 |
| 88203-04-7 | [(2-Acetylphenyl)amino]acetonitrile | C10H10N2O |